Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Inventory is also known as Days Sales of Inventory (DSI). BioGaia AB's Average Total Inventories for the
three
months ended in Jun. 2026 was $0.0 Mil. BioGaia AB's Cost of Goods Sold for the
three
months ended in Jun. 2026 was $12.8 Mil.
Hence, BioGaia AB's Days Inventory for the
three
months ended in Jun. 2026 was 0.00.
The historical rank and industry rank for BioGaia AB's Days Inventory or its related term are showing as below:
BIOGY'
s Days Inventory Range Over the Past 10 Years
Min: 75.4 Med: 135.36 Max: 170.76
Current: 142.63
During the past 13 years, BioGaia AB's highest Days Inventory was 170.76. The lowest was 75.40. And the median was 135.36.
BIOGY's Days Inventory is ranked better than 59.72% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.34
vs BIOGY: 142.63
BioGaia AB's Days Inventory
stayed the same
from Jun. 2025 () to Jun. 2026 ().
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioGaia AB's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.00.
BioGaia AB (OTCPK:BIOGY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioGaia AB's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioGaia AB's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BioGaia AB Days Inventory Related Terms
BioGaia AB Days Inventory Historical Data
* Premium members only.
The historical data trend for BioGaia AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioGaia AB Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioGaia AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is BioGaia AB (BIOGY) Overvalued in 2026?
Based on GuruFocus' analysis, BioGaia AB stock appears to be overvalued.
The current stock price of $12.45 is trading 6.3% above its estimated GF Value™ of $11.71.
GuruFocus considers BioGaia AB to be Fairly Valued.
Key valuation signals for BIOGY:
Days Inventory:
GF Value™: $11.71 vs. price of $12.45 (6.3% above fair value)
No single metric tells the full story. See the BIOGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
99GF Score
Get the complete analysis for BIOGY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOGY has been successfully added to your 
